BACKGROUND: Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency and the leading surgical cause of death in premature infants. We have shown that administration of exogenous heparin-binding epidermal growth factor-like growth factor (HB-EGF) in mice protects the intestines from experimental NEC. The aim of the current study was to evaluate the effect of gain-of-function of endogenous HB-EGF on susceptibility to NEC. METHODS: Neonatal HB-EGF transgenic (TG) mice and their wild-type (WT) counterparts were exposed to experimental NEC. An additional group of HB-EGF TG pups were also exposed to NEC, but received the HB-EGF antagonist cross-reacting material 197 (CRM197) injected subcutaneously immediately after birth. To examine gut barrier function, HB-EGF TG and WT pups received intragastric fluorescein isothiocyanate-labeled dextran under basal and stressed conditions, and serum fluorescein isothiocyanate-labeled dextran levels were measured. RESULTS: Wild-type mice had an incidence of NEC of 54.2%, whereas HB-EGF TG mice had a significantly decreased incidence of NEC of 22.7% (P = .03). Importantly, administration of CRM197 to HB-EGF TG pups significantly increased the incidence of NEC to 65% (P = .004). HB-EGF TG mice had significantly decreased intestinal permeability compared to WT mice both under basal and stressed conditions. CONCLUSIONS: Our results provide evidence that overexpression of the HB-EGF gene decreases susceptibility to NEC and that administration of the HB-EGF antagonist CRM197 reverses this protective effect.
BACKGROUND:Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency and the leading surgical cause of death in premature infants. We have shown that administration of exogenous heparin-binding epidermal growth factor-like growth factor (HB-EGF) in mice protects the intestines from experimental NEC. The aim of the current study was to evaluate the effect of gain-of-function of endogenous HB-EGF on susceptibility to NEC. METHODS: Neonatal HB-EGFtransgenic (TG) mice and their wild-type (WT) counterparts were exposed to experimental NEC. An additional group of HB-EGF TG pups were also exposed to NEC, but received the HB-EGF antagonist cross-reacting material 197 (CRM197) injected subcutaneously immediately after birth. To examine gut barrier function, HB-EGF TG and WT pups received intragastric fluorescein isothiocyanate-labeled dextran under basal and stressed conditions, and serum fluorescein isothiocyanate-labeled dextran levels were measured. RESULTS: Wild-type mice had an incidence of NEC of 54.2%, whereas HB-EGF TG mice had a significantly decreased incidence of NEC of 22.7% (P = .03). Importantly, administration of CRM197 to HB-EGF TG pups significantly increased the incidence of NEC to 65% (P = .004). HB-EGF TG mice had significantly decreased intestinal permeability compared to WT mice both under basal and stressed conditions. CONCLUSIONS: Our results provide evidence that overexpression of the HB-EGF gene decreases susceptibility to NEC and that administration of the HB-EGF antagonist CRM197 reverses this protective effect.
Authors: D W McCarthy; M T Downing; D R Brigstock; M H Luquette; K D Brown; M S Abad; G E Besner Journal: J Invest Dermatol Date: 1996-01 Impact factor: 8.551
Authors: M S Caplan; R Miller-Catchpole; S Kaup; T Russell; M Lickerman; M Amer; Y Xiao; R Thomson Journal: Gastroenterology Date: 1999-09 Impact factor: 22.682
Authors: J A Abraham; D Damm; A Bajardi; J Miller; M Klagsbrun; R A Ezekowitz Journal: Biochem Biophys Res Commun Date: 1993-01-15 Impact factor: 3.575
Authors: Bo Li; Carol Lee; Augusto Zani; Elke Zani-Ruttenstock; Wan Ip; Lijun Chi; Paul Delgado Olguin; Tanja Gonska; Agostino Pierro Journal: Pediatr Surg Int Date: 2014-10-31 Impact factor: 1.827
Authors: M H Premkumar; G Sule; S C Nagamani; S Chakkalakal; A Nordin; M Jain; M Z Ruan; T Bertin; B Dawson; J Zhang; D Schady; N S Bryan; P M Campeau; A Erez; B Lee Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-06-05 Impact factor: 4.052
Authors: Steven J McElroy; Shannon L Castle; Jessica K Bernard; Dana Almohazey; Catherine J Hunter; Brandon A Bell; Denise Al Alam; Larry Wang; Henri R Ford; Mark R Frey Journal: Am J Pathol Date: 2014-09-09 Impact factor: 4.307